Oct 23 (Reuters) - CSL Ltd CSL.AX :
* SEQIRUS RECEIVES FDA APPROVAL OF AFLURIA® QUADRIVALENT (INFLUENZA VACCINE) FOR PEOPLE SIX MONTHS OF AGE AND OLDER IN THE U.S.
* SEQIRUS RECEIVES FDA APPROVAL OF AFLURIA® QUADRIVALENT (INFLUENZA VACCINE) FOR PEOPLE SIX MONTHS OF AGE AND OLDER IN THE U.S.
* CSL LTD - APPROVAL ALSO APPLIES TO TRIVALENT FORMULATION OF AFLURIA